Edmond de Rothschild Holding’s Atossa Therapeutics ATOS Stock Holding History

Edmond de Rothschild Holding’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,333	Closed	-$59.5K	–	633
2024 Q2	$59.5K	Hold	3,333	–	–	﹤0.01%	547
2024 Q1	$90K	Hold	3,333	–	–	﹤0.01%	523
2023 Q4	$44K	Hold	3,333	–	–	﹤0.01%	582
2023 Q3	$36.8K	Hold	3,333	–	–	﹤0.01%	587
2023 Q2	$63K	Hold	3,333	–	–	﹤0.01%	558
2023 Q1	$36.2K	Hold	3,333	–	–	﹤0.01%	619
2022 Q4	$26.4K	Hold	3,333	–	–	﹤0.01%	699
2022 Q3	$42K	Hold	3,333	–	–	﹤0.01%	677
2022 Q2	$55K	Hold	3,333	–	–	﹤0.01%	654
2022 Q1	$63K	Hold	3,333	–	–	﹤0.01%	650
2021 Q4	$80K	Hold	3,333	–	–	﹤0.01%	651
2021 Q3	$163K	Hold	3,333	–	–	﹤0.01%	565
2021 Q2	$316K	Hold	3,333	–	–	0.01%	478
2021 Q1	$106K	Buy	+3,333	New	+$122K	﹤0.01%	557

Other funds holding ATOS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Edmond de Rothschild Holding's ATOS Position: Q3 2024 in Review

Edmond de Rothschild Holding sold out of Atossa Therapeutics (ATOS) in Q3 2024, closing a stake of 3,333 shares — an estimated $59.5K sold.

Edmond de Rothschild Holding first reported a position in ATOS in Q1 2021 and held it in 14 quarters. The position peaked at $316K in Q2 2021. 86 funds tracked by Wall St. Rank hold ATOS as of Q3 2024.

Edmond de Rothschild Holding reported no remaining Atossa Therapeutics position as of Q3 2024 after selling out during the quarter.
Edmond de Rothschild Holding sold 3,333 Atossa Therapeutics shares in Q3 2024, an estimated $59.5K.
Edmond de Rothschild Holding first reported a position in Atossa Therapeutics in Q1 2021 and held it in 14 quarters.
Edmond de Rothschild Holding's Atossa Therapeutics position peaked at $316K in Q2 2021.
86 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2024.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2024, filed 14 Nov 2024.